约 2,190,000 个结果
在新选项卡中打开链接
  1. Baricitinib
    • 根据 2 个来源
    In a June 13 announcement, the U.S. Food and Drug Administration approved the use of the Janus kinase (JAK) inhibitor baricitinib as a treatment for severe alopecia areata, a disfiguring skin disease. It is the first approved treatment for alopecia areata, an autoimmune disorder that affects about 7 million people in the United States.

    FDA approves alopecia area…

    news.yale.edu
    On Monday, the Food and Drug Administration approved baricitinib, a once-a-day pill developed by the drugmaker Eli Lilly to treat alopecia areata, an autoimmune disease that triggers sudden hair loss. The drug was originally approved by the FDA in 2018 to treat rheumatoid arthritis.

    First alopecia treatment fo…

    nbcnews.com
  2. 其他用户还问了以下问题
    Could a drug help alopecia areata?
    The drug could help some of the estimated 7 million people in the U.S. with alopecia areata, an autoimmune disorder in which the body’s immune system attacks hair follicles. As a result, hair falls out—often in clumps. The hair loss can affect any part of the body, although it usually affects the head and face, including eyebrows and eyelashes.

    New Alopecia Areata Treatment Aims To Help Adults and Adolescents

    yalemedicine.org
    Is there a second treatment for alopecia areata?
    Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease — both the result of pioneering research by the same Yale dermatologist.

    FDA approves second Yale-researched treatment for alopecia areata

    news.yale.edu
    Can alopecia areata be treated?
    The FDA approved a treatment for adults with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year.

    FDA Approves First Systemic Treatment for Alopecia Areata

    fda.gov
    Can ritlecitinib treat alopecia?
    The FDA has now approved a new drug to treat hair loss caused by alopecia. On June 23, the FDA announced approval for ritlecitinib, sold under the brand name Litfulo, a drug used to treat severe alopecia areata. The medicine has been approved for people 12 years and up. Alopecia areata is an autoimmune disease that results in hair loss.

    FDA Approves Drug Hair Loss Treatment for Alopecia - Healthline

    healthline.com
    Why is FDA approval important for alopecia areata?
    FDA approval has an additional benefit, as well. When a medicine is approved for treatment of a disease, doctors feel more comfortable prescribing the medicine for that purpose. Therefore, FDA approval will empower and enable health care providers to treat patients with severe alopecia areata.

    FDA approves alopecia areata treatment with roots at Yale

    news.yale.edu
    Is baricitinib the first approved treatment for alopecia areata?
    In a Q&A, Brett King discusses the FDA’s announcement of the drug baricitinib as the first-ever approved treatment for the autoimmune disorder alopecia areata.

    FDA approves alopecia areata treatment with roots at Yale

    news.yale.edu
    反馈
  3. Pfizer
    https://www.pfizer.com › news › press-release › press...

    FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and ...

    标记:
    Fda Alopecia Drug
    Food and Drug Administration
    New Drug For Alopecia Areata
  4. YaleNews
    https://news.yale.edu › fda-approves...

    FDA approves second Yale-researched treatment for …

    2023年6月26日 · Dr. Brett King, an associate professor of dermatology at Yale School of Medicine, has led clinical trials for ritlecitinib and baricitinib, two oral medicines that can regrow hair in people with alopecia areata. Learn how …

    标记:
    Fda Alopecia Drug
    Food and Drug Administration
    Yale University
  6. Healthline
    https://www.healthline.com › health-news › fda...

    Hair Loss: FDA Approves New Treatment for Alopecia - Healthline

  7. Yale Medicine
    https://www.yalemedicine.org › news › new-alopecia...

    New Alopecia Areata Treatment Aims To Help Adults and …

    标记:
    Yale University
    Alopecia areata
    Eli Lilly
    [email protected]
  8. Smithsonian Magazine
    https://www.smithsonianmag.com › smart-news › fda...

    FDA Approves First Drug to Treat Hair Loss Caused By Alopecia

    标记:
    Fda Alopecia Drug
    Food and Drug Administration
    Baricitinib For Alopecia Areata
  9. MIT News
    https://news.mit.edu › new-treatment-c…

    New treatment could reverse hair loss caused by an

    2024年5月9日 · Researchers developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss. The microneedle patch delivers immune-regulating molecules that can teach T cells not to attack hair …

    标记:
    Alopecia areata
    Massachusetts Institute of Technology
  10. Food and Drug Administration (.gov)
    https://www.fda.gov › news-events › press...

    FDA Approves First Systemic Treatment for Alopecia Areata

    标记:
    Fda Alopecia Drug
    Food and Drug Administration
    Baricitinib For Alopecia Areata
  11. Nature
    https://www.nature.com › articles

    FDA approves Pfizer's JAK inhibitor for adolescents …

    2023年7月27日 · In 2022, the FDA and the European Medicines Agency approved the first JAK inhibitor for adults with severe alopecia areata: Eli Lilly’s baricitinib. In phase 3 trials, 38.8% of adult patients ...

    标记:
    Baricitinib For Alopecia Areata
    Adult
  12. YaleNews
    https://news.yale.edu › fda-approves...

    FDA approves alopecia areata treatment with roots at …

    In a June 13 announcement, the U.S. Food and Drug Administration approved the use of the Janus kinase (JAK) inhibitor baricitinib as a treatment for severe alopecia areata, a disfiguring skin disease. It is the first approved treatment …

    标记:
    Food and Drug Administration
    Baricitinib For Alopecia Areata
    Hair Loss and Baldness
  13. NBC News
    https://www.nbcnews.com › health › he…

    First alopecia treatment for autoimmune disorder that …

    2022年6月14日 · On Monday, the Food and Drug Administration approved baricitinib, a once-a-day pill developed by the drugmaker Eli Lilly to treat alopecia areata, an autoimmune disease that triggers sudden hair...

    标记:
    Fda Alopecia Drug
    Food and Drug Administration
    Hair Loss and Baldness